LB230 – A Regulatory Illusion, Not a Ban

Nebraska's LB230, effective July 1, 2025, creates a "Kratom Consumer Protection Act." It sets an age limit of 21, requires product registration with the Department of Revenue, caps 7‑hydroxymitragynine at 2% of the alkaloid fraction, and mandates labeling. It does not ban kratom. It does not remove the product from gas stations or vape shops. It does not require testing for heavy metals, ethanol, or other contaminants. And it explicitly preempts local governments from enacting stronger restrictions or bans.

Why the Nebraska KCPA is a Deadly Failure

• The 2% 7‑OH cap is unenforceable. There is no field test for 7‑hydroxymitragynine. Law enforcement cannot verify compliance at the point of sale. Determining the cap requires laboratory analysis (LC‑MS/MS) that is expensive, slow, and not available to local police. The cap is a political number, not a real‑world safety limit.
• Enforcement is assigned to the Department of Revenue, not health or law enforcement. Tax collectors are not toxicologists. The department has no expertise in drug safety, poisonings, or addiction. The law ensures that enforcement will be complaint‑driven and toothless.
• No mandatory testing for lead, ethanol, or adulterants. Independent labs have repeatedly found lead at unsafe levels and ethanol concentrations as high as 15‑16% in liquid extracts – legally alcoholic. LB230 requires a certificate of analysis for alkaloid content only. It does not require testing for heavy metals, residual solvents, or biological contaminants. A product can be perfectly "registered" and still poison consumers.
• The "good faith" defense for retailers. Section 10(5) states that a retailer is not in violation if it relied in good faith on a processor's representation. This creates a massive loophole. Retailers can simply point to a piece of paper and avoid fines, while dangerous products continue to be sold.
• Preemption of local bans. Section 15 explicitly prohibits political subdivisions from imposing restrictions greater than those in the act. Cities and counties that want to ban kratom entirely are barred from doing so. The state has locked in a weak framework and stripped local governments of their authority to protect their communities.
• It legitimizes an FDA‑disputed substance. The FDA has repeatedly stated that kratom is not lawfully marketed as a dietary supplement and has no approved medical use. LB230 creates a state‑sanctioned commercial pathway for a product the federal government still considers unsafe. This creates dangerous confusion for consumers who assume "regulated" means "safe."
• No funding for real oversight. The law allows the Department of Revenue to charge fees, but it does not appropriate meaningful resources for testing, inspection, or enforcement. In practice, the system will be largely self‑certification by the industry. Processors submit their own certificates of analysis. Retailers rely on processor claims. There is no independent, proactive surveillance.
• The 2% cap ignores the bigger problem. Mitragynine itself is an opioid agonist with high abuse potential. The law does nothing to limit mitragynine concentration or total dose. Manufacturers can simply increase serving size to deliver dangerous amounts of mitragynine while staying under the 7‑OH cap.

Bottom line: LB230 is not consumer protection. It is an industry‑friendly framework that gives kratom a government seal of approval, preempts local bans, and provides no meaningful enforcement. The only honest answer is repeal and a full Schedule I ban.

The Only Answer: Repeal LB230 and Pass a Full Schedule I Ban

Nebraska should not regulate kratom. It should prohibit it – plain and simple. A full Schedule I ban removes kratom from every gas station, vape shop, and online retailer. No 2% cap games, no preemption of local bans, no enforcement by tax collectors.

If the legislature wants to address kratom, it must do so by ending its sale entirely – not by creating a regulated market that is impossible to enforce and provides false reassurance to the public.

What You Can Do Right Now

• Document retail sales in your community. Take photos of kratom displays in gas stations, vape shops, and stores near schools. Capture extracts, powders, shots, and any wellness or intoxication marketing. These images build a powerful record for lawmakers.
• Build local awareness. Many Nebraskans don't know that the KCPA passed – or that it does almost nothing to protect them. Share educational materials with parents, healthcare professionals, educators, local officials, and community groups.
• Recruit stakeholders. Use the list below to connect with pharmacists, physicians, nurses, addiction professionals, law enforcement, educators, and parents. Ask each organization to support repeal of the KCPA and a full ban.
• Follow developments in other states. Bans in states like Nevada and failures of KCPA bills in Idaho, South Carolina, and Wyoming provide lessons and evidence for Nebraska lawmakers.
• Prepare for the next session. Legislative action moves quickly. Build local networks, share educational materials, document retail activity, contact community leaders, and prepare testimony and evidence packets for lawmakers to demand repeal and replacement with a full ban.

Nebraska Organizations & Stakeholders – Build the Coalition for Repeal

Below are key Nebraska groups that can influence future kratom policy. For each category, we explain why they matter and what to ask when you reach out. Use the contact links to start the conversation.

Law Enforcement & Public Safety

Why they matter: No field test means no enforcement. Law enforcement can explain to legislators why a 2% cap is unenforceable and why a full ban is the only workable solution.

What to ask: "Will you support repeal of the KCPA and a full ban on all kratom products? Can you testify that the absence of a field test makes the current law unenforceable?"

Health & Poison Control

Why they matter: The Poison Center tracks substance use, poisoning data, and treatment needs. Their analysis can quantify the burden of kratom and justify a ban.

What to ask: "Will you collect and publish data on kratom-related emergency visits and poisonings? Will you support a full ban?"

Pharmacy

Why they matter: Pharmacists, the Board of Pharmacy, and pharmacy schools have direct knowledge of product safety, contamination risks, and the limitations of self‑regulation. They can advocate for a full ban.

What to ask: "Will your organization issue a public statement supporting a full statewide ban on kratom and calling for repeal of the KCPA? Will you provide data on adverse events or poisoning calls?"

Medical & Hospital Associations

Why they matter: Physicians, pediatricians, nurses, and hospitals see kratom's harms firsthand. Their public statements carry significant weight with legislators.

What to ask: "Will your organization issue a public statement supporting a full statewide ban on kratom? Will you share data on kratom-related ER visits or poisonings?"

Addiction Treatment & Recovery Centers

Why they matter: These providers see the real‑world consequences of kratom dependence – withdrawal, failed treatment attempts, and relapse. Their testimony can illustrate the addictive nature of kratom.

What to ask: "Will you support a full ban and provide testimony or written comments about the burden of kratom addiction on your programs?"

Prepare Messages for the Next Session – Repeal and Ban

LB230 is now law, but it can be repealed. Use the template below to educate legislators about why the KCPA is a failure and why a full ban is necessary.

Call Script for Stakeholder Outreach